- Home
- SPH vs PSTX Comparison
SPH vs PSTX Comparison
Compare SPH & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- PSTX
- Stock Information
- Founded
- SPH 1945
- PSTX 2014
- Country
- SPH United States
- PSTX United States
- Employees
- SPH N/A
- PSTX N/A
- Industry
- SPH Other Specialty Stores
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPH Consumer Discretionary
- PSTX Health Care
- Exchange
- SPH Nasdaq
- PSTX Nasdaq
- Market Cap
- SPH 1.1B
- PSTX 909.4M
- IPO Year
- SPH 1996
- PSTX 2020
- Fundamental
- Price
- SPH $18.08
- PSTX $9.52
- Analyst Decision
- SPH Hold
- PSTX Hold
- Analyst Count
- SPH 3
- PSTX 3
- Target Price
- SPH $19.67
- PSTX $9.00
- AVG Volume (30 Days)
- SPH 192.2K
- PSTX 2.6M
- Earning Date
- SPH 02-06-2025
- PSTX 11-07-2024
- Dividend Yield
- SPH 7.23%
- PSTX N/A
- EPS Growth
- SPH N/A
- PSTX N/A
- EPS
- SPH 1.14
- PSTX N/A
- Revenue
- SPH $1,327,172,000.00
- PSTX $150,858,000.00
- Revenue This Year
- SPH N/A
- PSTX $131.92
- Revenue Next Year
- SPH $1.22
- PSTX N/A
- P/E Ratio
- SPH $15.77
- PSTX N/A
- Revenue Growth
- SPH N/A
- PSTX 203.18
- 52 Week Low
- SPH $15.20
- PSTX $1.87
- 52 Week High
- SPH $22.33
- PSTX $9.58
- Technical
- Relative Strength Index (RSI)
- SPH 39.61
- PSTX 88.59
- Support Level
- SPH $18.80
- PSTX $9.35
- Resistance Level
- SPH $19.41
- PSTX $9.56
- Average True Range (ATR)
- SPH 0.53
- PSTX 0.08
- MACD
- SPH -0.17
- PSTX -0.09
- Stochastic Oscillator
- SPH 13.46
- PSTX 76.67
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.